Respiratory Muscle Aids in the Management of Neuromuscular Respiratory Impairment to Prevent Respiratory Failure and Need for Tracheostomy by A. J. Hon & J. R. Bach
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Respiratory Muscle Aids in the Management of 
Neuromuscular Respiratory Impairment  
to Prevent Respiratory Failure and  
Need for Tracheostomy 
A. J. Hon and J. R. Bach  
Department of Physical Medicine and Rehabilitation,  
UMDNJ-New Jersey Medical School  
USA 
1. Introduction 
Respiratory impairment results from primary disease of the lungs / airways or from 
impairment of the respiratory muscles. The proper identification of the respiratory 
impairment allows for proper management to decrease morbidity and mortality. Patients 
with neuromuscular impairment typically have hypoventilation or ventilator 
insufficiency/failure resulting in hypercapnia, hypoxia and an ineffective cough. In contrast, 
lung and airway diseases are characterized by hypoxia with eucapnia or hypocapnia, which 
often occur during an exacerbation resulting in acute respiratory failure (ARF). Often 
physicians evaluate and treat both as respiratory insufficiency/failure.  
Historically and even currently, when neuromuscular patients develop respiratory failure the 
traditional paradigm has been resorting to tracheostomy, resulting in increasing weakness of 
inspiratory muscles and loss of ventilator free breathing ability. In contrast, we and others with 
neuromuscular patient populations, successfully use a new management paradigm including 
noninvasive interfaces for intermittent positive pressure ventilation (NIV) in place of 
tracheostomy (TIV) to maintain not only life but also quality of life (Bach, 2010). It has been 
noted previously that patient populations prefer NIV over TIV both overall and specifically 
with regards to comfort, convenience, speech, swallowing, cosmesis, and safety (Bach, 1993). 
NIV can provide from intermittent up to continuous ventilatory support for patients with 
advanced neuromuscular disease who have normal lung tissue but respiratory muscle 
weakness. These concepts and techniques can be used for any patient with respiratory 
muscle weakness, for example high level traumatic spinal cord injury and polio patients 
(Bach, 1991; Bach & Alba, 1990; Bach et al., 1989). Even in patients with severely 
dysfunctional expiratory muscles with little to no vital capacity or maximum expiratory 
pressures, noninvasive pressure aids can provide effective cough flows. The inability to 
cough up secretions, due to an ineffective cough, often results in mucous plugging of the 
airways, but when using noninvasive ventilatory muscle aids, a cough can be augmented 
for effective and sufficient secretion removal.  
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Inspiratory and expiratory muscle aids, including devices and manual assisted techniques, 
result in intermittent pressure changes to assist inspiratory and expiratory muscles in their 
natural function. Noninvasive inspiratory and expiratory muscle aids are used to maintain 
lung and chest wall compliance, maintain normal alveolar ventilation, and to maximize cough 
peak flows (CPF) thus preventing episodes of acute respiratory failure, especially during 
intercurrent chest infections. This allows for decreased hospitalizations and prolongs survival 
without tracheostomy for patients with Duchenne muscular dystrophy (DMD), Spinal 
Muscular Atrophy including type 1 (SMA), amyotrophic lateral sclerosis (ALS), and others.  
2. Pathophysiology 
Respiratory muscle groups include inspiratory muscles (predominately the diaphragm), 
expiratory muscles (predominately abdominal and chest wall muscles used for coughing) 
and bulbar-innervated muscles (used to protect the airway). Many patients with ventilatory 
insufficiency manage for years without ventilator use but at the cost of orthopnea and 
hypercapnia which can result in compensatory metabolic alkalosis which depresses central 
ventilatory drive. As a result the brain becomes accustomed to the hypercapnia without 
obvious symptoms of ventilatory failure. Patients not introduced to NIV are oftentimes 
prescribed supplemental oxygen which exacerbates hypercapnia and eventually results in 
the coma of carbon dioxide narcosis and ventilatory arrest.  
Patients with inspiratory and expiratory muscle weakness can be sustained using NIV. 
Ventilatory insufficiency/failure spans the spectrum from those with only diaphragm 
dysfunction (resulting in nocturnal ventilatory insufficiency/failure when in bed) to 
complete inspiratory muscle failure. Patients with complete inspiratory and expiratory 
muscle failure (with as little as 0 mL of vital capacity) can be completely supported using 
NIV for over 50 years without tracheostomy (Bach, 2004). Some of them use only nocturnal 
ventilatory aids and use glossopharyngeal breathing (GPB) to maintain ventilation during 
the day (Bach, 2004). 
3. Evaluating a patient  
On initial presentation, ambulatory patients with hypercapnic ventilatory insufficiency often 
initially report exertional dyspnea and later morning headaches, fatigue, sleep disturbances 
and hypersomnolence (Bach & Alba, 1990). On the other hand wheelchair users may report 
wheelchair users may report very few symptoms, e.g., anxiety, dyspnea, and difficulty with 
sleep, except during a respiratory infection. Physical signs of tachypnea, paradoxical 
breathing, hypophonia, nasal flaring, accessory respiratory muscle use, cyanosis, flushing, 
pallor and airway secretion and congestion are signs of increasing carbon dioxide levels. 
Lethargy and confusion are indicative of carbon dioxide narcosis, which can be reversed 
with proper management through NIV.  
Evaluation can include obtaining a vital capacity (VC), cough peak flows (CPF), 
capnography/oximetry and a polysomnogram. VC is measured in the supine and sitting 
positions. The VC supine is a superior indicator of ventilatory dysfunction as 
hypoventilation begins and is worse during sleep. The difference between the two should be 
less than 7 percent, while a value greater than 20 percent indicates need for nocturnal NIV. 
If the patient wears a thoracolumbar brace, a VC should be recorded with and without the 
brace as the fit can improve or worsen the VC.  
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Spirometry is also used for monitoring the maximum insufflation capacity (MIC), that is, the 
ability to “air stack”. The ability to air stack is holding with the glottis a maximal volume by 
holding consecutively delivered volumes of air delivered from a manual resuscitator or 
volume cycling ventilator. Interfaces that can be used for air stacking include a simple 
mouthpiece or when the lips are too weak for this, a nasal interface or lipseal. In patients 
who have learned glossopharyngeal breathing (GPB) techniques, this enables them to 
approach or attain the MIC independently.  
Cough Peak Flow (CPF), measured with a peak flow meter, is an indicator of the patient’s 
cough effectiveness. A CPF of 160 L/m is the minimum needed for sufficiently effective 
coughing and airway clearance to reliably permit safe extubation (Bach & Saporito, 1996). 
This is also the best indicator for tracheostomy removal, regardless of pulmonary function, 
that is, the status of the inspiratory and expiratory muscles. Patients with a VC of less than 
1,500 mL should have  an assisted CPF measured using a maximal lung volume by air 
stacking  and an abdominal thrust for a manually assisted cough. The abdominal thrust 
should be delivered  simultaneously to the opening of the glottis. 
In patients without significant intrinsic lung disease, arterial blood gas sampling is 
unnecessary. Many patients (25%) tend to hyperventilate due to discomfort or anxiety from 
the procedure (Currie et al., 1986), so accurate results can be difficult to obtain. Oximetry 
monitoring and capnography, which is the measurement of end tidal pCO2, provide more 
useful information. Most conveniently they can be performed in the home.  
Patients with questionable symptoms, multiple hourly nocturnal oxyhemoglobin 
desaturations to below 95%, and elevated nocturnal PaCO2 should undergo a trial of 
nocturnal NIV. If the questionably symptomatic patient finds nocturnal NIV to be more 
burdensome than the symptoms of ventilatory insufficiency, the patient can discontinue 
NIV and should be reevaluated in 3 to 6 months.  
In symptomatic patients with a normal VC, no carbon dioxide retention and no clear pattern 
of oxyhemoglobin desaturation, a polysomnogram is warranted to evaluate for sleep 
disordered breathing (Williams et al., 1991). Patients with obesity-hypoventilation also 
should be treated with NIV or pressure or volume control ventilation and not CPAP. 
Neuromuscular disease NMD patients with decreased VC have no indication for 
undergoing polysomnography as the device is programmed to interpret each apnea and 
hypopnea as having a central nervous system or obstructive etiology rather than being due 
to inspiratory muscle weakness. Treatment of asymptomatic NMD patients based solely on 
polysomnographic abnormalities with continuous positive airway pressure (CPAP) or low 
spans of bi-level PAP is ineffective or at the least, suboptimal.  
4. Lung expansion therapy 
Lung expansion therapy often results in increasing VC, increasing CPF, maintaining or 
increasing pulmonary compliance, decreasing atelectasis and facilitating introduction of 
NIV. Various devices and techniques have been developed to prolong survival without 
tracheotomy through maintaining pulmonary compliance, and augmenting inspiratory and 
expiratory muscle function. For example, researchers have found that Duchenne muscular 
dystrophy patients requiring up to continuous ventilator dependence as NIV, can avoid 
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hospitalizations, pulmonary morbidity and mortality for decades and tracheotomy 
indefinitely when properly managed with respiratory muscle aids (Gomez-Merino & Bach, 
2002). Forty percent of ALS patients can survive for almost a year on average and up to 8 
years without a tracheostomy tube despite continuous ventilator dependence supplied via 
NIV (Bach et al., 2004).  
4.1 Maintaining pulmonary compliance 
Maintaining pulmonary (chest wall and lung) compliance, constantly and consistently 
maintaining normal alveolar ventilation, and maximizing cough peak flows are essential to 
preventing episodes of ARF, avoiding hospitalizations and prolonging survival without 
tracheotomy. Particularly for children, maintaining chest wall/lung compliance promotes 
more normal lung and chest wall growth. Regular lung and chest wall mobilization is done 
by air stacking, receiving deep insufflations, or using nocturnal NIV for small children who 
cannot cooperate with air stacking (Bach et al., 2000). With increasing respiratory  
muscle weakness, the patient cannot expand the lungs to the predicted inspiratory capacity. 
This results in chest wall contractures and lung restriction (decreased pulmonary 
compliance).  
Regular mobilization through deep insufflations, air stacking or NIV can result in an 
increase in VC and CPF. The degree to which the MIC exceeds the VC (MIC-VC) indicates 
glottis/bulbar innervated muscle integrity and correlates with the ability to use NIV rather 
than require tracheotomy. The Lung Insufflation Capacity (LIC) is the maximum passive 
insufflation volume using the assistance of a device (Bach & Kang, 2000).  
In patients with inability to close the glottis, insufflation can be achieved passively through 
the use of a Cough AssistTM, pressure cycling ventilator with pressures 40 to 70 cm H2O, or 
using a manual resuscitator with the exhalation valve blocked to air stack (Figure 1). 
Patients are instructed to air stack at least 10 to 15 times, 2 to 3 times a day once the VC is 
found to have decreased below 80% of predicted normal. For NIV users, volume cycling is 
preferable to pressure cycling as it enables air stacking and this allows for increased volume 
of voice (Bach et al., 2008). In patients with primarily ventilatory impairment, CPAP is not 
useful since it does not aid inspiratory or expiratory muscles.  
In addition, patients who are able to air stack are also able to use NIV. If at any point the 
patient is intubated, he or she can more easily be extubated directly to NIV regardless of 
ventilator free breathing ability (VFBA). Proper instruction is essential as the extubation of 
inexperienced patients without VFBA to NIV can at times result in panic, ventilator 
dyssynchrony, asphyxia or even reintubation.  
In patients, such as infants, who can not cooperate with active insufflation therapy, that is, 
who are unable to air stack, oral-nasal interfaces are used for deep passive insufflations. 
Infants with spinal muscular atrophy (SMA) of any type or any neuromuscular disease with 
paradoxical chest wall movement require nocturnal NIV to promote normal chest wall/lung 
growth, prevent pectus excavatum, as well as possibly for ventilatory assistance (Bach et al., 
2002). Often by 14 to 30 months children can become cooperative with deep insufflation 
therapy. 
Respiratory Muscle Aids in the Management of Neuromuscular  
Respiratory Impairment to Prevent Respiratory Failure and Need for Tracheostomy 239 
 
Fig. 1. Patient demonstrating air stacking using a manual resuscitator. 
4.2 Inspiratory muscle assistance 
Historically, negative pressure body ventilators have been used to apply pressure to the 
body for ventilatory support, but this is less effective than NIV as they can cause obstructive 
apneas and are decreasingly efficacious with increasing age and decreasing pulmonary 
compliance (Bach et al, 1989). In figure 2, the intermittent abdominal pressure ventilator 
(IAPV) or “Exsufflation Belt” is a body ventilator that can augment tidal volumes from 300 
to 1,200 mL. The intermittent inflation of the elastic air sac worn in a corset or belt under the 
patient’s clothing moves the diaphragm upward to assist in expiration. With bladder 
deflation, passive inspiration occurs with the diaphragm and abdominal contents returning 
to resting position with gravity. For effective use the trunk must be 30 degrees or more from 
the horizontal. Patients with inspiratory capacity or ability to glossopharyngeal breathe can 
add volumes of air to those mechanically taken in. Patients with less than one hour of 
breathing tolerance usually prefer it to NIV during daytime hours (Bach & Alba, 1991).  
Inspiratory muscles can be assisted using NIV. There are no contraindications to long term 
use of NIV other than uncontrollable seizures. Multiple interfaces can be used and they can 
be introduced to the patients in a clinic or home setting. They include 15 mm angled mouth 
pieces, lipseals, and nasal and oral-nasal interfaces. Open NIV systems include mouthpiece 
or nasal NIV which rely on central nervous system reflexes to prevent insufflation air 
leakage during sleeping (Bach &Alba, 1990; Bach et al., 1955). A closed system, such as by 
using a lipseal-nasal prong system, can avoid excessive leakage by delivering air via mouth 
and nose during sleep (Figure 3). In addition to minimizing insufflation leakage, they 
maximize skin comfort. Using nocturnal NIV improves daytime O2 and CO2. Supplemental 
O2 and sedatives should be avoided to maintain maximal nocturnal NIV effectiveness.  
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Fig. 2. High level spinal cord injured patient with no measurable vital capacity or ventilator-
free breathing ability using an intermittent abdominal pressure ventilator for daytime 
ventilatory assistance (Exsufflation BeltTM, Philips-Respironics International Inc., 
Murrysville, PA) and using a lipseal for nocturnal support for 15 years.  
 
Fig. 3. Duchenne muscular dystrophy patient using an interface that includes nasal prongs 
with lip covering to provide a closed system of ventilatory support during sleep, here seen 
using it during surgery with general anesthesia. 
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In patients with some neck movement and lip function, the 15 mm angled mouthpiece 
interface is the most useful, and is able to be used by some patients all day (Ishikawa, 2005). 
Often times patients can keep the mouthpiece near the mouth with a metal clamp attached 
to the wheelchair or affixed onto the motorized wheelchair controls, most commonly the sip 
and puff, chin or tongue controls. The patient can grab the mouthpiece for supplemental air 
or full breath support, as demonstrated in Figure 4.  
The volume ventilator is set for large tidal volumes, commonly 800 to 1500 mL. Therefore, 
the patient can control the volume of air obtained and can use air stacking to cough, increase 
speech volumes, and maintain pulmonary compliance. To use mouthpiece NIV a patient 
must be able to move the soft palate posteriocranially to seal off the nasopharynx, open the 
glottis and vocal cords, and maintain hypopharynx and airway patency. These movements 
quickly become reflexive. They must and usually can be quickly relearned by patients who 
have been ventilated via tracheostomy and have lost them (Bach et al., 1993).  
 
Fig. 4. A 66 year old woman with multiple sclerosis and continuous ventilator dependence 
using a 15 mm angled mouth piece for daytime support for 27 years despite having only 30 
mL of vital capacity.  
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For those who are unable to grab or maintain a tight seal on a mouthpiece for daytime NIV, 
such as infants,  nasal NIV using small nasal prong systems can be ideal and can be used 
continuously as a viable alternative to tracheostomy (Bach & Alba, 1990). To prevent oral 
insufflation leakage during nasal NIV, patients learn to close the mouth or seal the 
oropharynx with the soft palate and tongue. Humidifying the air is essential for nocturnal 
mouthpiece/lipseal ventilation but infrequently for nocturnal nasal NIV. Suboptimal 
humidification results in dry, irritated mucous membranes and increased airflow resistance 
to up to 8 cm H2O (Richards et al., 1996). The air can be warmed to body temperature and 
humidified using a hot water bath humidifier to decrease irritation of nasal membranes 
(Richards et al., 1996).  
Complications from NIV are few. At times abdominal distension can occur sporadically. 
The air usually passes as flatus when the patient is mobilized in the morning. If severe, it 
can increase ventilator dependence and result in necessary placement of a gastrostomy or 
nasogastric tube to burp out the air or a rectal tube to decompress the colon. In 1000 NIV 
users there was noted to be one case of pneumothorax despite aggressive lung 
mobilization and expansion three times daily with NIV support for most and, indeed for 
over 50 years in many cases (Suri et al., 2008). Often mistakenly noted to be a complication 
or limiting aspect of NIV, secretion management remains the most important aspect of 
noninvasive management.  
4.3 Cough Augmentation: Expiratory muscle assistance 
Cough Augmentation is essential in maintaining the health of patients with a poor cough 
due to weak expiratory muscles. Essential techniques include manually assisted coughing, 
mechanically assisted coughing (MAC), glossopharyngeal breathing, and oximetry 
monitoring to guide in airway clearance when using these techniques. Routine suctioning 
through the upper airway or indwelling airway tubes misses the left main stem bronchus 90 
percent of the time (Fishburn et al., 1990). Manually assisted coughing is the application of 
an abdominal thrust timed to glottis opening after filling the lungs maximally with air, 
usually through air stacking, Figure 5A and Figure 5B.  
The air stacking is important for patients with less than 1500 mL VC. With air stacking, 
manually assisted coughing has produced air flows of 4.3 ± 1.7 L/sec compared to 2.5 ± 2.0 
L/sec unassisted (Kang & Bach, 2000). In our population of 364 NMD patient able to air 
stack the mean VC in the sitting position was 996.9 mL, while the mean MIC by air stacking 
was 1647.6 mL. Upper airway obstruction, often due to severe bulbar-innervated muscle 
dysfunction, is indicated by the inability to generate 160 L/m of assisted CPF with a VC or 
MIC greater than 1 L. With CPF this low, the airway should be evaluated by laryngoscopy 
and reversible lesions corrected surgically. 
Mechanical insufflation-exsufflation (CoughAssistTM) augments or substitutes for 
inspiratory and expiratory muscles. Both mechanical and manually assisted cough 
techniques provide effective exsufflation flows in the left and right airways, allowing for 
their use in place of deep suctioning. Patients prefer MAC compared with suctioning for 
comfort and effectiveness, in addition to finding it less tiring (Gastang et al., 2000).  
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Fig. 5.A. Manually assisted coughing with abdominal thrust applied concomittant with 
glottic opening following air stacking with flows to be measured by peak flow meter. 
 
 
Fig. 5.B. Assisted cough peak flow measured by peak flow meter. 
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4.3.1 Mechanically assisted coughing 
Mechanically assisted coughing (MAC) combines mechanical insufflation-exsufflation with 
an exsufflation-timed abdominal thrust to increase CPF. The CoughAssistTM can be 
manually or automatically cycled with the deep insufflations followed immediately by deep 
exsufflations, ideally with pressures of 40 to 60 alternating with -40 to -60 cm H2O. Interfaces 
for MAC include oral-nasal masks, a simple mouthpiece, or translaryngeal or tracheostomy 
tubes. With use via a tracheostomy tube, the cuff, if present, should be inflated. Manual 
cycling allows caregiver-patient coordination during inspiration and expiration with the 
insufflation and exsufflation.  
Treatments can be as frequent as up to every 30 minutes during respiratory infections and 
post-extubation. One treatment set includes about five cycles of MAC followed by a short 
period of normal breathing or ventilator use to avoid hyperventilation. When patients 
cannot cooperate with MAC, the timing of the insufflation and exsufflation is adjusted to the 
patient’s breathing to provide maximum chest expansion and rapid lung emptying, in 
general 2 to 4 seconds for adults but much more quickly for small children. Treatments 
continue until no further secretions are able to be removed and oxyhemoglobin desaturation 
due to mucus plugging is reversed. The abdominal thrust is also important for infants. By 
2.5 to 5 years of age, children become accustomed to coughing simultaneously with the 
insufflation-exsufflation. 
With the elimination of airway secretions and mucus using MAC, vital capacity, abnormal 
pulmonary flow rates and oxyhemoglobin saturation can improve immediately (Bach et al., 
1993). Fifteen percent to 42 percent increase in VC was noted immediately following MAC 
for 67 patients with “obstructive dyspnea” and a 55 percent increase in VC was noted in 
patients with neuromuscular conditions (Barach, 1954). In ventilator assisted neuromuscular 
disease patients with chest infections, a 15 to 400 percent (200 to 800 mL) increase was noted 
following secretion removal with MAC (Bach, 1993). 
Although MAC can augment and even substitute for the inspiratory and expiratory 
muscles, if bulbar innervated muscles, which prevent airway collapse and protect against 
food and saliva aspiration, are inadequately functioning, tracheotomy becomes indicated. 
However, this is generally only observed in advanced bulbar ALS patients. Patients with 
intact bulbar muscle function can usually air stack to volumes of 3 L or more, and, unless 
very scoliotic or obese, a properly delivered abdominal thrust can result in assisted CPF of 6 
to 9 L/s, which is sufficient to clear secretions  and prevent pneumonia and ARF without 
requiring MAC. Those with moderately impaired bulbar muscle function, e.g., non-ALS 
neuromuscular disease patients like those with Duchenne muscular dystrophy, that limits 
assisted CPF to less than 300 L/m benefit the most from MAC (Gomez-Merino, 2002). 
4.3.2 Glossopharyngeal Breathing 
Glossopharyngeal Breathing (GPB) is a technique that involves “gulping” boluses of air into 
the lungs using the glottis to add to the inspiratory effort. Six to 9 gulps (40 mL to 200 mL) 
total a full breath. The technique can be taught, to assist inspiratory and indirectly 
expiratory muscle function in patients with good bulbar-innervated musculature (Bach et 
al., 1987), allowing for discontinuation of ventilator use from minutes up to a whole day. 
Initial training can be supplemented with a training manual and videos (Dail et al., 1979; 
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Dail & Affeldt, 1954). The patient’s developing proficiency can be monitored using 
spirometry to measure the milliliter of air per gulp, gulps per breath and the breaths per 
minute as seen in Figure 6.  
 
Fig. 6. Glossopharyngeal breathing used for 6 liters of minute ventilation in “gulps” of 60 to 
90 mL or 6 to 8 gulps per breath, 12 breaths per minute, for autonomous respiration despite 
having 0 mL of vital capacity for 52 years (Bach et al., 1987).  
Normal minute ventilation and normal alveolar ventilation can be maintained by 
glossopharyngeal breathing for individuals with little to no measurable vital capacity. 
Autonomous breathing is possible from minutes to up to all day by using it. It has been 
noted that 60% of ventilator users with no autonomous ability to breathe and sufficient 
bulbar muscle function can use GPB for ventilator-free breathing (Bach et al., 1987; Bach & 
Alba, 1990). This technique is ideal in the event of ventilator failure or disconnection  during 
the day or night (Bach et al., 1987; Bach, 1991). The versatility and safety afforded by GPB 
are safeguards that make noninvasive management safer than support via tracheostomy. 
Although severe oropharyngeal muscle weakness can limit the effectiveness of GPB, 13 
Duchenne muscular dystrophy patients with no breathing tolerance could be maintained 
solely with GPB (Bach et al. 2007).  
4.3.3 Oximetry monitoring 
Oximetry monitoring, through the use of a pulse oximeter, is essential in managing patients 
with NMD using respiratory muscle aids. A SpO2 alarm set at 94% alerts the patient to take 
deeper breaths to maintain SpO2 consistently over 94% all day (Gomez-Marino & Bach, 
2002), and when tiring, to take ventilator assisted breaths usually via a mouthpiece. Thus, 
SpO2 feedback provides a method to monitor a hypercapnic patient with desaturation due to 
chronic alveolar hypoventilation and during transition from tracheostomy ventilation. If the 
patient is unable to independently maintain a sufficient level of at least SpO2 of 94%, 
mouthpiece or nasal NIV should be initiated for increasing periods to maintain normal SpO2 
which helps to reset central ventilatory drive. Thereby, oximetry feedback facilitates the 
introduction and indicates the extent of daytime need for mouthpiece and/or nasal NIV. In 
addition, oximetry monitoring is especially useful during episodes of respiratory tract 
infection as an indicator to use MAC to prevent cold triggered pneumonias and acute 
respiratory failure, usually due to mucus plugging in the NIV patient population. Proper 
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instruction of NIV and MAC, and rapid access to MAC during the onset of a chest cold may 
be all that is necessary to avert pneumonia, ARF and subsequent hospitalizations.  
Especially in infants and small children, with often inadequate cough to prevent chest colds 
from triggering pneumonia and ARF, MAC should be used for any desaturation below 95 
percent. In continuous NIV users, desaturations are usually due to bronchial mucus plugging, 
which can develop into atelectasis and pneumonia if the secretions are not quickly cleared.  
5. Contraindications to noninvasive aids: Invasive ventilatory support 
Certain patient populations are better managed with tracheostomy. Contraindications to 
noninvasive aid include ventilator dependence with depressed cognitive function, 
orthopedic conditions interfering with noninvasive interface use, restrictive pulmonary 
syndrome along with severe pulmonary disease necessitating high FiO2, or uncontrolled 
seizures or substance abuse (Waldhornet al., 1990). In addition, the presence of a nasogastric 
tube can hamper the fitting of a nasal interface and the use of mouthpiece or nasal NIV by 
limiting soft palate closure of the pharynx and the necessary seal at the nose. For 
neuromuscular disease patients, only those with severe bulbar dysfunction, as observed 
with severe bulbar ALS resulting in the inability for protect the airway, require tracheotomy 
(Bach et al., 2004). Other than for the occasional spinal muscular atrophy type 1 patient, 
tracheotomy is rarely if ever indicated for Duchenne muscular dystrophy or any other 
neuromuscular disease (Bach et al., 2009). Although tracheostomy ventilation can support 
alveolar ventilation and extend survival for many NMD patients (Bach, 1996), morbidity 
and mortality outcomes are not as favorable as by noninvasive approaches (Bach et al., 1998; 
Toussaint et al., 2006).   
6. Long term outcomes 
A number of centers have reported up to continuous NIV dependence to maintain patients 
with neuromuscular disease. One hundred and one of our nocturnal only NIV users became 
continuously NIV dependent for 7.6 ± 6.1 years to 30.1 ± 6.1 years of age with 56 patients 
still living. Twenty six became continuously dependent on NIV without requiring 
hospitalization, while eight continuous tracheostomy ventilation users were decanulated to 
noninvasive NIV. Using the above described techniques for the DMD patient population, 
we have extubated 31 “unweanable” intubated patients consecutively to NIV/MAC without 
resort to tracheotomy (Bach & Martinez, 2001). Also reported by Kohler et al., continuous 
NIV can prolong life in DMD. Seven of our DMD patients have lived to over 40 years of age 
requiring continuous NIV for 20 years or more. 
Of our 71 SMA type 1 patients sustained with NIV, (mean age 86.1 months (range 13–196) with 
only 13 deaths at 52.3 months (range 13-111)), fifteen SMA-1 patients are over age 10 and 6 
over age 15 without tracheostomy tubes and despite requiring continuous NIV in most cases 
(Bach et al., 2009). Sixty seven of the patient population could verbally communicate. Schroth 
also reported use of continuous NIV for SMA type 1 patients (2009). Of seventeen SMA type 1 
patients using tracheostomy ventilation with mean age 78.2 months (range 65–179), 25 of 27 
lost all autonomous breathing ability immediately upon tracheotomy. Those who had not 
developed verbalization prior to tracheotomy did not develop vocalization following the 
procedure. Two brothers with SMA-1 are pictured initially at age 4 then at age 14 and 16 with 
no VC sustained entirely with NIV (Figure 7 and Figure 8). 
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Fig. 7. Two brothers with spinal muscular atrophy type 1 and continuous ventilator 
dependence since 4 months of age. 
 
Fig. 8. The same brothers as in Figure 7, now 16 and 14 years of age and with no measurable 
vital capacity. 
In our 176 ALS patients using nocturnal NIV, 42 percent (109 ALS patients) progressed to 
requiring continuous NIV due to progression of disease, developing severe bulbar innervated 
muscle impairment that would eventually lead to requiring tracheotomy. Significant 
aspiration, resulting in consistent baseline SpO2 desaturations to below 95%, due to the 
weakness of bulbar innervated muscles is the sole indication for tracheotomy in NMD. 
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7. Extubation of “unweanable” patient 
Using new NMD specific extubation criteria and protocol, including MAC and pulse 
oximetry monitoring, “unweanable” patients with DMD, SMA, ALS, and other 
neuromuscular diseases, e.g., SCI and polio, were successfully extubated to NIV (Bach, 
2010).  
 
Extubation Criteria for Unweanable Ventilator Dependent Patients 
1. Afebrile and normal white blood cell count 
2. PaCO2 40 mm Hg or less at peak inspiratory pressures less than 30 cm H2O on full 
ventilatory support and normal breathing rate, as needed 
3. Oxyhemoglobin saturation (SpO2) ≥ 95% for 12 hours or more in ambient air 
4. All oxyhemoglobin desaturations below 95% reversed by mechanically assisted 
coughing and suctioning via translaryngeal tube 
5. Fully alert and cooperative, receiving no sedative medications 
6. Chest radiograph abnormalities cleared or clearing 
7. Air leakage via upper airway sufficient for vocalization upon cuff deflation 
Table 1. Adapted from Bach, J.R. (2010). Extubation of Patients With Neuromuscular 
Weakness. Chest, 137( 5), 1033-1039 
The extubation criteria and protocol have been developed for the neuromuscular disease 
specific patient population. Instead of spontaneous breathing trials which patients typically 
undergo prior to extubation attempts, once a NMD patient meets the criteria cited in Table 
1, he or she can be directly extubated to nasal NIV, assist control 800 to 1500 mL and rate 10-
14 breaths/minute in ambient air, with aggressive MAC. Ideally the orogastric or nasogastic 
tube should be removed to facilitate proper fitting of the NIV interface which can be nasal, 
oro-nasal and/or mouthpiece interfaces.  
As the patient receives full volume support via NIV, the assisted CPF, or CPF obtained by 
abdominal thrust following air stacking, is measured within 3 hours of extubation. Patients 
with sufficient neck movement and lip function used the 15 mm angled mouthpiece and 
weaned themselves as tolerated by taking fewer and fewer positive pressure ventilations. 
For those unable to effectively use the 15 mm mouth piece, diurnal nasal NIV was used via 
nasal prongs, with a nasal or oronasal interface used for nocturnal ventilation. Patients were 
educated and trained in air stacking and manually assisted coughing and assisted and 
unassisted CPF were measured.  
For SpO2<95%, ventilator positive inspiratory pressure (PIP), interface or tubing air leakage, 
CO2 retention, ventilator settings, and MAC were considered. Therapists, nurses, and 
especially family and personal care attendants were trained and provided with a 
CoughAssistTM to use MAC via oro-nasal interfaces up to every 30 min until airway 
secretions cleared and SpO2 could be maintained consistently above 94 percent. Open 
gastrostomies were performed under local anesthesia using NIV without complication in 7 
patients with unsafe post-extubation oral intake.  
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One hundred and fifty seven consecutive “unweanable” patients were treated including 25 
with SMA, 20 with DMD, 16 with ALS, 17 with spinal cord injury, 11 with postpolio 
syndrome, and 68 with other NMD. Eighty three of these were transferred from other 
hospitals after refusing tracheostomy after inability to pass spontaneous breathing trials. 
They were successfully extubated to NIV and MAC despite being unable to pass 
spontaneous breathing trials before or after extubation. Not requiring re-intubation during 
the hospitalization defined extubation success. Prior to hospitalization 96 (61%) patients had 
no experience with NIV, 41 (26%) used it part-time, and 20 (13%) were continuously NIV 
dependent. 
There was an extubation success rate of 95% (149 patients) on first attempt. On patients with 
assisted CPF ≥ 160 L/m, all 98  extubations were successful. Six of 8 patients who had 
assisted CPF less than 160 L/m initially failed extubation but succeeded on subsequent 
attempts (Bach et al, 2010). Only two bulbar ALS patients with no measurable assisted CPF 
underwent tracheotomy (Bach et al., 2010). Multiple centers now routinely extubate DMD 
patients to NIV directly to avoid tracheotomy.  
8. “Unweanable” patient decannulation 
In 1996 we initially reported the decannulation of 50 unweanable patients with 
neuromuscular weakness (Bach & Saporito, 1996). Any ventilator dependent patient with 
sufficient bulbar-innervated musculature to prevent significant secretion aspiration is a 
candidate for decannulation to NIV. This is ideal as decanulation facilitates speech and 
swallowing. The basic principles for decannulation are essentially identical to those for 
extubation. Patients with tracheostomy tubes and with no VFBA, possessing VC of 250 mL 
or greater developed VFBA subsequent to decannulation. Within 3 weeks of decannulation, 
most weaned to only nocturnal NIV.  
9. Conclusion 
The ability to decannulate and maintain survival of neuromuscular disease patients using 
NIV in place of tracheostomies is indeed possible, and in fact preferable regarding aspects of 
convenience, speech, swallowing, cosmesis, comfort, safety, and is preferred overall (Bach, 
1993). The extubation criteria set forth is a simple evaluation of patients with NMD 
(ventilatory muscle weakness) compared with the extensive “ventilator weaning 
parameters” used as criteria along with spontaneous breathing trials considered  
for the extubation of patients with intrinsic/obstructive lung diseases before extubating 
them.  
To maintain a sufficient SpO2 of greater than 94 percent, inspiratory and expiratory muscle 
aid is used to prevent and manage desaturations and hypercapnia instead of supplemental 
oxygen. “Unweanable” patients, with sufficient glottic function to prevent significant 
aspiration of secretions, can be extubated to NIV and maintained on NIV for many years, 
averting tracheostomy. In the NMD patient population, with primarily ventilatory muscle 
weakness rather than intrinsic lung disease, this alternative paradigm provides optimal 
management and quality of life.  
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